Lineage Cell Therapeutics, Inc.
LCTX
Revenue
1.50M
▼-1.37M▼-47.63%
3 Months ChangeAssets
111.75M
▼-1.47M▼-1.29%
3 Months ChangeLiabilities
34.10M
▼-2.11M▼-5.82%
3 Months ChangeFree Cash Flow
-4.98M
▲838.00k▲14.40%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-094004
2024-08-08
Form 8-K
ID: 0000950170-24-093947
2024-06-14
Form 8-K
ID: 0000950170-24-073769
2024-06-13
Form 8-K
ID: 0000950170-24-073072
2024-05-14
Form 8-K
ID: 0000950170-24-059689
2024-05-09
Form 10-Q
ID: 0000950170-24-056998
2024-05-09
Form 8-K
ID: 0000950170-24-056948
2024-03-22
Form 8-K
ID: 0000950170-24-035365
2024-03-07
Form 8-K
ID: 0000950170-24-027951
2024-02-15
Form 8-K
ID: 0001493152-24-006901